[ORGANIZATION]
U.S. Food and Drug Administration
Featured in 3 tracked stories · first seen
Situations
GLP‑1 market, safety, usage & consumer trends
174 clusters · 621 sources · last updated
Latest: GLP‑1 weight‑loss drugs face scrutiny over microdosing and side‑effect risks
GLP‑1 receptor agonists have become a mainstream weight‑loss option, with usage spreading across primary‑care, tele‑health and Medicare‑CMS subsidies. Market value is projected near $105 billion by 2030. Safety signals c
Merck Lipfendra oral PCSK9 approval
4 clusters · 51 sources · last updated
Latest: FDA approves Merck's oral PCSK9 inhibitor Lipfendra to lower LDL cholesterol
The U.S. Food and Drug Administration has confirmed approval of Merck’s Lipfendra (enlicitil‑de), the first once‑daily oral tablet that inhibits the PCSK9 protein. Clinical trials in more than 3,200 adults with primary h
Also covered in
-
Rise of Over-the-Counter and Smart Hearing Aids Expands Access Worldwide
[HEALTH] · 3 sources ·